Publications by authors named "Dean Stamos"

Claim this Profile
P
Palladium (II)-Catalyzed C-H Activation with Bifunctional Ligands: From Curiosity to Industrialization.
Kevin Wu, Nelson Lam, Daniel A Strassfeld, Zhoulong Fan, Jennifer X Qiao, Dean Stamos

Angew Chem Int Ed Engl· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
DCAF11 Supports Targeted Protein Degradation by Electrophilic Proteolysis-Targeting Chimeras.
Xiaoyu Zhang, Lena M Luukkonen, Christie L Eissler, Vincent M Crowley, Yu Yamashita, Dean Stamos

J Am Chem Soc· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel CCR2 antagonist inhibits atherogenesis in apoE deficient mice by achieving high receptor occupancy.
Ilze Bot, Natalia V Ortiz Zacarías, Wilhelmus E A de Witte, Henk de Vries, Peter J van Santbrink, Dean Stamos

Sci Rep· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structure of CC chemokine receptor 2 with orthosteric and allosteric antagonists.
Yi Zheng, Ling Qin, Natalia V Ortiz Zacarías, Henk de Vries, Gye Won Han, Dean Stamos

Nature· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Ligand-Promoted C(sp(3) )-H Olefination en Route to Multi-functionalized Pyrazoles.
Weibo Yang, Shengqing Ye, Yvonne Schmidt, Dean Stamos, Jin-Quan Yu

Chemistry· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
N-Heterocyclic Carbene Ligand-Enabled C(sp(3))-H Arylation of Piperidine and Tetrahydropyran Derivatives.
Shengqing Ye, Weibo Yang, Timothy Coon, Dewey Fanning, Tim Neubert, Dean Stamos

Chemistry· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of (4-Arylpiperidin-1-yl)cyclopentanecarboxamides As High-Affinity and Long-Residence-Time Antagonists for the CCR2 Receptor.
Maris Vilums, Annelien J M Zweemer, Arian Dilanchian, Jacobus P D van Veldhoven, Henk de Vries, Dean Stamos

ChemMedChem· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radical mediated C-H functionalization of 3,6-dichloropyridazine: efficient access to novel tetrahydropyridopyridazines.
Timothy D Neubert, Yvonne Schmidt, Erica Conroy, Dean Stamos

Org Lett· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
When structure-affinity relationships meet structure-kinetics relationships: 3-((Inden-1-yl)amino)-1-isopropyl-cyclopentane-1-carboxamides as CCR2 antagonists.
Maris Vilums, Annelien J M Zweemer, Farhana Barmare, Anouk M F van der Gracht, Dave C T Bleeker, Dean Stamos

Eur J Med Chem· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of novel oxazepine and diazepine carboxamides as two new classes of heat shock protein 90 inhibitors.
Timothy Neubert, Mehdi Numa, Justin Ernst, Jeremy Clemens, Paul Krenitsky, Dean Stamos

Bioorg Med Chem Lett· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Orchestrated triple C-H activation reactions using two directing groups: rapid assembly of complex pyrazoles.
Weibo Yang, Shengqing Ye, Dewey Fanning, Timothy Coon, Yvonne Schmidt, Dean Stamos

Angew Chem Int Ed Engl· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Strategies for the modulation of phase II metabolism in a series of PKCε inhibitors.
Jeremy J Clemens, Timothy Coon, Brett B Busch, Juliana L Asgian, Sarah Hudson, Dean Stamos

Bioorg Med Chem Lett· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Successful application of serum shift prediction models to the design of dual targeting inhibitors of bacterial gyrase B and topoisomerase IV with improved in vivo efficacy.
Emanuele Perola, Dean Stamos, Anne-Laure Grillot, Steven Ronkin, Tiansheng Wang

Bioorg Med Chem Lett· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of novel HSP90α/β isoform selective inhibitors using structure-based drug design. demonstration of potential utility in treating CNS disorders such as Huntington's disease.
Justin T Ernst, Timothy Neubert, Michael Liu, Samuel Sperry, Harmon Zuccola, Dean Stamos

J Med Chem· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correlation between chemotype-dependent binding conformations of HSP90α/β and isoform selectivity-Implications for the structure-based design of HSP90α/β selective inhibitors for treating neurodegenerative diseases.
Justin T Ernst, Michael Liu, Harmon Zuccola, Timothy Neubert, Kevin Beaumont, Dean Stamos

Bioorg Med Chem Lett· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multiple binding sites for small-molecule antagonists at the CC chemokine receptor 2.
Annelien J M Zweemer, Indira Nederpelt, Hilde Vrieling, Sarah Hafith, Maarten L J Doornbos, Dean Stamos

Mol Pharmacol· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structure-kinetic relationships--an overlooked parameter in hit-to-lead optimization: a case of cyclopentylamines as chemokine receptor 2 antagonists.
Maris Vilums, Annelien J M Zweemer, Zhiyi Yu, Henk de Vries, Julia M Hillger, Dean Stamos

J Med Chem· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diastereoselective one-pot Knoevenagel condensation/Corey-Chaykovsky cyclopropanation.
Jeremy J Clemens, Juliana L Asgian, Brett B Busch, Timothy Coon, Justin Ernst, Dean Stamos

J Org Chem· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of pyrazolthiazoles as novel and potent inhibitors of bacterial gyrase.
Steven M Ronkin, Michael Badia, Steve Bellon, Anne-Laure Grillot, Christian H Gross, Dean Stamos

Bioorg Med Chem Lett· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel dual-targeting benzimidazole urea inhibitors of DNA gyrase and topoisomerase IV possessing potent antibacterial activity: intelligent design and evolution through the judicious use of structure-guided design and structure-activity relationships.
Paul S Charifson, Anne-Laure Grillot, Trudy H Grossman, Jonathan D Parsons, Michael Badia, Dean Stamos

J Med Chem· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dual targeting of GyrB and ParE by a novel aminobenzimidazole class of antibacterial compounds.
Trudy H Grossman, Douglas J Bartels, Steve Mullin, Christian H Gross, Jonathan D Parsons, Dean Stamos

Antimicrob Agents Chemother· February 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vitro characterization of the antibacterial spectrum of novel bacterial type II topoisomerase inhibitors of the aminobenzimidazole class.
Nagraj Mani, Christian H Gross, Jonathan D Parsons, Brian Hanzelka, Ute Müh, Dean Stamos

Antimicrob Agents Chemother· April 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis